BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Axelrod H, Pienta KJ. Axl as a mediator of cellular growth and survival. Oncotarget 2014;5:8818-52. [PMID: 25344858 DOI: 10.18632/oncotarget.2422] [Cited by in Crossref: 95] [Cited by in F6Publishing: 103] [Article Influence: 13.6] [Reference Citation Analysis]
Number Citing Articles
1 Al Kafri N, Ahnström J, Teraz-orosz A, Chaput L, Singh N, Villoutreix BO, Hafizi S. The first laminin G-like domain of protein S is essential for binding and activation of Tyro3 receptor and intracellular signalling. Biochemistry and Biophysics Reports 2022;30:101263. [DOI: 10.1016/j.bbrep.2022.101263] [Reference Citation Analysis]
2 Adams DE, Zhen Y, Qi X, Shao WH. Axl Expression in Renal Mesangial Cells Is Regulated by Sp1, Ap1, MZF1, and Ep300, and the IL-6/miR-34a Pathway. Cells 2022;11:1869. [PMID: 35740998 DOI: 10.3390/cells11121869] [Reference Citation Analysis]
3 Li J, Jia H, Tian M, Wu N, Yang X, Qi J, Ren W, Li F, Bian H. SARS-CoV-2 and Emerging Variants: Unmasking Structure, Function, Infection, and Immune Escape Mechanisms. Front Cell Infect Microbiol 2022;12:869832. [DOI: 10.3389/fcimb.2022.869832] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Anderson SR, Roberts JM, Ghena N, Irvin EA, Schwakopf J, Cooperstein IB, Bosco A, Vetter ML. Neuronal apoptosis drives remodeling states of microglia and shifts in survival pathway dependence. Elife 2022;11:e76564. [PMID: 35481836 DOI: 10.7554/eLife.76564] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Abou Khouzam R, Zaarour RF, Brodaczewska K, Azakir B, Venkatesh GH, Thiery J, Terry S, Chouaib S. The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes? Front Immunol 2022;13:828875. [PMID: 35211123 DOI: 10.3389/fimmu.2022.828875] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
6 Sang YB, Kim JH, Kim CG, Hong MH, Kim HR, Cho BC, Lim SM. The Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges. Front Oncol 2022;12:811247. [PMID: 35311091 DOI: 10.3389/fonc.2022.811247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Egan G, Phuagkhaopong S, Matthew SAL, Connolly P, Seib FP. Impact of silk hydrogel secondary structure on hydrogel formation, silk leaching and in vitro response. Sci Rep 2022;12:3729. [PMID: 35260610 DOI: 10.1038/s41598-022-07437-4] [Reference Citation Analysis]
8 Zwernik SD, Adams BH, Raymond DA, Warner CM, Kassam AB, Rovin RA, Akhtar P. AXL receptor is required for Zika virus strain MR-766 infection in human glioblastoma cell lines. Mol Ther Oncolytics 2021;23:447-57. [PMID: 34901388 DOI: 10.1016/j.omto.2021.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chandrasekaran A, Dittlau KS, Corsi GI, Haukedal H, Doncheva NT, Ramakrishna S, Ambardar S, Salcedo C, Schmidt SI, Zhang Y, Cirera S, Pihl M, Schmid B, Nielsen TT, Nielsen JE, Kolko M, Kobolák J, Dinnyés A, Hyttel P, Palakodeti D, Gorodkin J, Muddashetty RS, Meyer M, Aldana BI, Freude KK. Astrocytic reactivity triggered by defective autophagy and metabolic failure causes neurotoxicity in frontotemporal dementia type 3. Stem Cell Reports 2021;16:2736-51. [PMID: 34678206 DOI: 10.1016/j.stemcr.2021.09.013] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Ohta S, Tago K, Kuchimaru T, Funakoshi-Tago M, Horie H, Aoki-Ohmura C, Matsugi J, Yanagisawa K. The role of MerTK in promoting cell migration is enhanced by the oncogenic Ras/IL-33 signaling axis. FEBS J 2021. [PMID: 34743410 DOI: 10.1111/febs.16271] [Reference Citation Analysis]
11 Hedrich V, Breitenecker K, Djerlek L, Ortmayr G, Mikulits W. Intrinsic and Extrinsic Control of Hepatocellular Carcinoma by TAM Receptors. Cancers (Basel) 2021;13:5448. [PMID: 34771611 DOI: 10.3390/cancers13215448] [Reference Citation Analysis]
12 Khamko R, Daduang J, Settasatian C, Limpaiboon T. OPCML Exerts Antitumor Effects in Cholangiocarcinoma via AXL/STAT3 Inactivation and Rho GTPase Down-regulation. Cancer Genomics Proteomics 2021;18:771-80. [PMID: 34697068 DOI: 10.21873/cgp.20296] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Burstyn-Cohen T, Hochberg A. TAM Signaling in the Nervous System. Brain Plast 2021;7:33-46. [PMID: 34631419 DOI: 10.3233/BPL-210125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Tanaka M, Siemann DW. Therapeutic Targeting of the Gas6/Axl Signaling Pathway in Cancer. Int J Mol Sci 2021;22:9953. [PMID: 34576116 DOI: 10.3390/ijms22189953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Novoyatleva T, Rai N, Kojonazarov B, Veeroju S, Ben-Batalla I, Caruso P, Shihan M, Presser N, Götz E, Lepper C, Herpel S, Manaud G, Perros F, Gall H, Ghofrani HA, Weissmann N, Grimminger F, Wharton J, Wilkins M, Upton PD, Loges S, Morrell NW, Seeger W, Schermuly RT. Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2. Commun Biol 2021;4:1002. [PMID: 34429509 DOI: 10.1038/s42003-021-02531-1] [Reference Citation Analysis]
16 Khera L, Lev S. Accelerating AXL targeting for TNBC therapy. Int J Biochem Cell Biol 2021;139:106057. [PMID: 34403827 DOI: 10.1016/j.biocel.2021.106057] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Bordoloi J, Ozah D, Bora T, Kalita J, Manna P. Gamma-glutamyl carboxylated Gas6 facilitates the prophylactic effect of vitamin K in inhibiting hyperlipidemia-associated inflammatory pathophysiology via arresting MCP-1/ICAM-1 mediated monocyte-hepatocyte adhesion. J Nutr Biochem 2021;93:108635. [PMID: 33789149 DOI: 10.1016/j.jnutbio.2021.108635] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Wium M, Ajayi-Smith AF, Paccez JD, Zerbini LF. The Role of the Receptor Tyrosine Kinase Axl in Carcinogenesis and Development of Therapeutic Resistance: An Overview of Molecular Mechanisms and Future Applications. Cancers (Basel) 2021;13:1521. [PMID: 33806258 DOI: 10.3390/cancers13071521] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
19 Aehnlich P, Powell RM, Peeters MJW, Rahbech A, Thor Straten P. TAM Receptor Inhibition-Implications for Cancer and the Immune System. Cancers (Basel) 2021;13:1195. [PMID: 33801886 DOI: 10.3390/cancers13061195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
20 Post SM, Andreeff M, DiNardo C, Khoury JD, Ruvolo PP. TAM kinases as regulators of cell death. Biochim Biophys Acta Mol Cell Res 2021;1868:118992. [PMID: 33647320 DOI: 10.1016/j.bbamcr.2021.118992] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Li W, Xie L, Ma J, Cheng M, Fan L, Xu Y, Wang B, Chen W. Gas6 or Mer deficiency ameliorates silica-induced autophagosomes accumulation in mice lung. Toxicol Lett 2021;337:28-37. [PMID: 33232774 DOI: 10.1016/j.toxlet.2020.11.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
22 Pietrobono S, Anichini G, Sala C, Manetti F, Almada LL, Pepe S, Carr RM, Paradise BD, Sarkaria JN, Davila JI, Tofani L, Battisti I, Arrigoni G, Ying L, Zhang C, Li H, Meves A, Fernandez-Zapico ME, Stecca B. ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL. Nat Commun 2020;11:5865. [PMID: 33203881 DOI: 10.1038/s41467-020-19575-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
23 Rossi F, Josey B, Sayitoglu EC, Potens R, Sultu T, Duru AD, Beljanski V. Characterization of zika virus infection of human fetal cardiac mesenchymal stromal cells. PLoS One 2020;15:e0239238. [PMID: 32941515 DOI: 10.1371/journal.pone.0239238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
24 Steiner CA, Rodansky ES, Johnson LA, Berinstein JA, Cushing KC, Huang S, Spence JR, Higgins PDR. AXL Is a Potential Target for the Treatment of Intestinal Fibrosis. Inflamm Bowel Dis 2021;27:303-16. [PMID: 32676663 DOI: 10.1093/ibd/izaa169] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
25 Al Kafri N, Hafizi S. Galectin-3 Stimulates Tyro3 Receptor Tyrosine Kinase and Erk Signalling, Cell Survival and Migration in Human Cancer Cells. Biomolecules 2020;10:E1035. [PMID: 32664510 DOI: 10.3390/biom10071035] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
26 Tanaka M, Siemann DW. Gas6/Axl Signaling Pathway in the Tumor Immune Microenvironment. Cancers (Basel) 2020;12:E1850. [PMID: 32660000 DOI: 10.3390/cancers12071850] [Cited by in Crossref: 12] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
27 Ndhlovu ZM, Kazer SW, Nkosi T, Ogunshola F, Muema DM, Anmole G, Swann SA, Moodley A, Dong K, Reddy T, Brockman MA, Shalek AK, Ndung'u T, Walker BD. Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection. Sci Transl Med 2019;11:eaau0528. [PMID: 31118290 DOI: 10.1126/scitranslmed.aau0528] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 12.5] [Reference Citation Analysis]
28 Landolt L, Furriol J, Babickova J, Ahmed L, Eikrem Ø, Skogstrand T, Scherer A, Suliman S, Leh S, Lorens JB, Gausdal G, Marti HP, Osman T. AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction. Physiol Rep 2019;7:e14091. [PMID: 31134766 DOI: 10.14814/phy2.14091] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
29 Lechertier T, Reynolds LE, Kim H, Pedrosa AR, Gómez-Escudero J, Muñoz-Félix JM, Batista S, Dukinfield M, Demircioglu F, Wong PP, Matchett KP, Henderson NC, D'Amico G, Parsons M, Harwood C, Meier P, Hodivala-Dilke KM. Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growth. Nat Commun 2020;11:2810. [PMID: 32499572 DOI: 10.1038/s41467-020-16618-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
30 Bae CA, Ham IH, Oh HJ, Lee D, Woo J, Son SY, Yoon JH, Lorens JB, Brekken RA, Kim TM, Han SU, Park WS, Hur H. Inhibiting the GAS6/AXL axis suppresses tumor progression by blocking the interaction between cancer-associated fibroblasts and cancer cells in gastric carcinoma. Gastric Cancer 2020;23:824-36. [PMID: 32239298 DOI: 10.1007/s10120-020-01066-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
31 Colavito SA. AXL as a Target in Breast Cancer Therapy. J Oncol 2020;2020:5291952. [PMID: 32148495 DOI: 10.1155/2020/5291952] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
32 Mende N, Jolly A, Percin GI, Günther M, Rostovskaya M, Krishnan SM, Oostendorp RAJ, Dahl A, Anastassiadis K, Höfer T, Waskow C. Prospective isolation of nonhematopoietic cells of the niche and their differential molecular interactions with HSCs. Blood 2019;134:1214-26. [PMID: 31366622 DOI: 10.1182/blood.2019000176] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
33 Zajac O, Leclere R, Nicolas A, Meseure D, Marchiò C, Vincent-Salomon A, Roman-Roman S, Schoumacher M, Dubois T. AXL Controls Directed Migration of Mesenchymal Triple-Negative Breast Cancer Cells. Cells 2020;9:E247. [PMID: 31963783 DOI: 10.3390/cells9010247] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
34 Xu C, Han Y, Xu S, Wang R, Yue M, Tian Y, Li X, Zhao Y, Gong P. Design, synthesis and biological evaluation of new Axl kinase inhibitors containing 1,3,4-oxadiazole acetamide moiety as novel linker. Eur J Med Chem 2020;186:111867. [PMID: 31757525 DOI: 10.1016/j.ejmech.2019.111867] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
35 Waterborg CEJ, Broeren MGA, Blaney Davidson EN, Koenders MI, van Lent PLEM, van den Berg WB, van der Kraan PM, van de Loo FAJ. The level of synovial AXL expression determines the outcome of inflammatory arthritis, possibly depending on the upstream role of TGF-β1. Rheumatology (Oxford) 2019;58:536-46. [PMID: 30508140 DOI: 10.1093/rheumatology/key337] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
36 Bassyouni RH, Gomaa AA, Hassan EA, Ali ESG, Khalil MAF, Mashahit MA, Gaber SN. Possible Association of Elevated Plasma Levels of Growth Arrest-Specific Protein 6 and the Soluble Form of Tyrosine Kinase Receptor Axl with Low Hepatitis C Viral Load in Patients with Type 2 Diabetes Mellitus. Viral Immunol 2020;33:105-11. [PMID: 31905327 DOI: 10.1089/vim.2019.0127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Patil SL, Palat A, Pan Y, Rajapakshe K, Mirchandani R, Bondesson M, Yustein JT, Coarfa C, Gunaratne PH. MicroRNA-509-3p inhibits cellular migration, invasion, and proliferation, and sensitizes osteosarcoma to cisplatin. Sci Rep 2019;9:19089. [PMID: 31836741 DOI: 10.1038/s41598-019-55170-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
38 Yamada Y, Nakamura-Yamada S, Umemura-Kubota E, Baba S. Diagnostic Cytokines and Comparative Analysis Secreted from Exfoliated Deciduous Teeth, Dental Pulp, and Bone Marrow Derived Mesenchymal Stem Cells for Functional Cell-Based Therapy. Int J Mol Sci 2019;20:E5900. [PMID: 31771293 DOI: 10.3390/ijms20235900] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
39 Al Kafri N, Hafizi S. Tumour-Secreted Protein S (ProS1) Activates a Tyro3-Erk Signalling Axis and Protects Cancer Cells from Apoptosis. Cancers (Basel) 2019;11:E1843. [PMID: 31766614 DOI: 10.3390/cancers11121843] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
40 Cho CY, Chung SY, Lin S, Huang JS, Chen YL, Jiang SS, Cheng LC, Kuo TH, Lay JD, Yang YY, Lai GM, Chuang SE. PTBP1-mediated regulation of AXL mRNA stability plays a role in lung tumorigenesis. Sci Rep 2019;9:16922. [PMID: 31729427 DOI: 10.1038/s41598-019-53097-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
41 Yan S, Vandewalle N, De Beule N, Faict S, Maes K, De Bruyne E, Menu E, Vanderkerken K, De Veirman K. AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma. Cancers (Basel) 2019;11:E1727. [PMID: 31694201 DOI: 10.3390/cancers11111727] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
42 Ahmadi R, Sepehri B, Ghavami R. Development linear and non-linear QSAR models for predicting AXL kinase inhibitory activity of N-[4-(quinolin-4-yloxy)phenyl]benzenesulfonamides. J Recept Signal Transduct Res 2019;39:264-75. [PMID: 31538847 DOI: 10.1080/10799893.2019.1660898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Azad T, Nouri K, Janse van Rensburg HJ, Maritan SM, Wu L, Hao Y, Montminy T, Yu J, Khanal P, Mulligan LM, Yang X. A gain-of-functional screen identifies the Hippo pathway as a central mediator of receptor tyrosine kinases during tumorigenesis. Oncogene 2020;39:334-55. [PMID: 31477837 DOI: 10.1038/s41388-019-0988-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 10.7] [Reference Citation Analysis]
44 Jimbo T, Hatanaka M, Komatsu T, Taira T, Kumazawa K, Maeda N, Suzuki T, Ota M, Haginoya N, Isoyama T, Fujiwara K. DS-1205b, a novel selective inhibitor of AXL kinase, blocks resistance to EGFR-tyrosine kinase inhibitors in a non-small cell lung cancer xenograft model. Oncotarget 2019;10:5152-67. [PMID: 31497246 DOI: 10.18632/oncotarget.27114] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
45 Espindola MS, Habiel DM, Narayanan R, Jones I, Coelho AL, Murray LA, Jiang D, Noble PW, Hogaboam CM. Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 2018;197:1443-56. [PMID: 29634284 DOI: 10.1164/rccm.201707-1519OC] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 12.7] [Reference Citation Analysis]
46 Salmi L, Gavelli F, Patrucco F, Caputo M, Avanzi GC, Castello LM. Gas6/TAM Axis in Sepsis: Time to Consider Its Potential Role as a Therapeutic Target. Dis Markers 2019;2019:6156493. [PMID: 31485279 DOI: 10.1155/2019/6156493] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
47 Veeranki OL, Tong Z, Dokey R, Mejia A, Zhang J, Qiao Y, Singh PK, Katkhuda R, Mino B, Tailor R, Canales JR, Bassett R, Ajani J, Wu JY, Kopetz S, Blum M, Hofstetter W, Tetzlaff M, Krishnan S, Lin SH, Maru D. Targeting cyclin-dependent kinase 9 by a novel inhibitor enhances radiosensitization and identifies Axl as a novel downstream target in esophageal adenocarcinoma. Oncotarget 2019;10:4703-18. [PMID: 31384397 DOI: 10.18632/oncotarget.27095] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
48 Ding AS, Routkevitch D, Jackson C, Lim M. Targeting Myeloid Cells in Combination Treatments for Glioma and Other Tumors. Front Immunol 2019;10:1715. [PMID: 31396227 DOI: 10.3389/fimmu.2019.01715] [Cited by in Crossref: 20] [Cited by in F6Publishing: 29] [Article Influence: 6.7] [Reference Citation Analysis]
49 Badi I, Mancinelli L, Polizzotto A, Ferri D, Zeni F, Burba I, Milano G, Brambilla F, Saccu C, Bianchi ME, Pompilio G, Capogrossi MC, Raucci A. miR-34a Promotes Vascular Smooth Muscle Cell Calcification by Downregulating SIRT1 (Sirtuin 1) and Axl (AXL Receptor Tyrosine Kinase). Arterioscler Thromb Vasc Biol 2018;38:2079-90. [PMID: 30026277 DOI: 10.1161/ATVBAHA.118.311298] [Cited by in Crossref: 44] [Cited by in F6Publishing: 66] [Article Influence: 14.7] [Reference Citation Analysis]
50 Cohen PL, Shao WH. Gas6/TAM Receptors in Systemic Lupus Erythematosus. Dis Markers 2019;2019:7838195. [PMID: 31360267 DOI: 10.1155/2019/7838195] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
51 Desai A, Small EJ. Treatment of advanced renal cell carcinoma patients with cabozantinib, an oral multityrosine kinase inhibitor of MET, AXL and VEGF receptors. Future Oncol 2019;15:2337-48. [PMID: 31184937 DOI: 10.2217/fon-2019-0021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
52 Batlle M, Castillo N, Alcarraz A, Sarvari S, Sangüesa G, Cristóbal H, García de Frutos P, Sitges M, Mont L, Guasch E. Axl expression is increased in early stages of left ventricular remodeling in an animal model with pressure-overload. PLoS One 2019;14:e0217926. [PMID: 31181097 DOI: 10.1371/journal.pone.0217926] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
53 Myers KV, Amend SR, Pienta KJ. Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment. Mol Cancer 2019;18:94. [PMID: 31088471 DOI: 10.1186/s12943-019-1022-2] [Cited by in Crossref: 74] [Cited by in F6Publishing: 117] [Article Influence: 24.7] [Reference Citation Analysis]
54 Suresh D, Zambre A, Mukherjee S, Ghoshdastidar S, Jiang Y, Joshi T, Upendran A, Kannan R. Silencing AXL by covalent siRNA-gelatin-antibody nanoconjugate inactivates mTOR/EMT pathway and stimulates p53 for TKI sensitization in NSCLC. Nanomedicine 2019;20:102007. [PMID: 31085346 DOI: 10.1016/j.nano.2019.04.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
55 Kim D, Bach DH, Fan YH, Luu TT, Hong JY, Park HJ, Lee SK. AXL degradation in combination with EGFR-TKI can delay and overcome acquired resistance in human non-small cell lung cancer cells. Cell Death Dis 2019;10:361. [PMID: 31043587 DOI: 10.1038/s41419-019-1601-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 36] [Article Influence: 9.7] [Reference Citation Analysis]
56 Tanaka M, Siemann DW. Axl signaling is an important mediator of tumor angiogenesis. Oncotarget 2019;10:2887-98. [PMID: 31080559 DOI: 10.18632/oncotarget.26882] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
57 Chen SY, Chiang CF, Chiu KC, Cheng CW, Huang SM, Chen PH, Chen CY, Shieh YS. Macrophage phenotypes and Gas6/Axl signaling in apical lesions. J Dent Sci 2019;14:281-7. [PMID: 31528256 DOI: 10.1016/j.jds.2018.12.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
58 Chen FF, Song FQ, Chen YQ, Wang ZH, Li YH, Liu MH, Li Y, Song M, Zhang W, Zhao J, Zhong M. Exogenous testosterone alleviates cardiac fibrosis and apoptosis via Gas6/Axl pathway in the senescent mice. Exp Gerontol 2019;119:128-37. [PMID: 30710682 DOI: 10.1016/j.exger.2019.01.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
59 Holstein E, Binder M, Mikulits W. Dynamics of Axl Receptor Shedding in Hepatocellular Carcinoma and Its Implication for Theranostics. Int J Mol Sci 2018;19:E4111. [PMID: 30567378 DOI: 10.3390/ijms19124111] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
60 Shen Y, Zhang W, Liu J, He J, Cao R, Chen X, Peng X, Xu H, Zhao Q, Zhong J, Ding W, Lei X, Jiang Y, Zu X. Therapeutic activity of DCC-2036, a novel tyrosine kinase inhibitor, against triple-negative breast cancer patient-derived xenografts by targeting AXL/MET. Int J Cancer 2019;144:651-64. [PMID: 30289981 DOI: 10.1002/ijc.31915] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
61 Wium M, Paccez JD, Zerbini LF. The Dual Role of TAM Receptors in Autoimmune Diseases and Cancer: An Overview. Cells 2018;7:E166. [PMID: 30322068 DOI: 10.3390/cells7100166] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
62 Gorisse L, Li Z, Hedman AC, Sacks DB. IQGAP1 binds the Axl receptor kinase and inhibits its signaling. Biochem J 2018;475:3073-86. [PMID: 30185434 DOI: 10.1042/BCJ20180594] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
63 Axelrod HD, Valkenburg KC, Amend SR, Hicks JL, Parsana P, Torga G, DeMarzo AM, Pienta KJ. AXL Is a Putative Tumor Suppressor and Dormancy Regulator in Prostate Cancer. Mol Cancer Res 2019;17:356-69. [PMID: 30291220 DOI: 10.1158/1541-7786.MCR-18-0718] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
64 Zhang M, Qian C, Zheng ZG, Qian F, Wang Y, Thu PM, Zhang X, Zhou Y, Tu L, Liu Q, Li HJ, Yang H, Li P, Xu X. Jujuboside A promotes Aβ clearance and ameliorates cognitive deficiency in Alzheimer's disease through activating Axl/HSP90/PPARγ pathway. Theranostics 2018;8:4262-78. [PMID: 30128052 DOI: 10.7150/thno.26164] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 9.3] [Reference Citation Analysis]
65 Gao L, Liu X, Millstein J, Siegmund KD, Dubeau L, Maguire RL, Jim Zhang J, Fuemmeler BF, Kollins SH, Hoyo C, Murphy SK, Breton CV. Self-reported prenatal tobacco smoke exposure, AXL gene-body methylation, and childhood asthma phenotypes. Clin Epigenetics 2018;10:98. [PMID: 30029617 DOI: 10.1186/s13148-018-0532-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
66 Zhen Y, Lee IJ, Finkelman FD, Shao WH. Targeted inhibition of Axl receptor tyrosine kinase ameliorates anti-GBM-induced lupus-like nephritis. J Autoimmun 2018;93:37-44. [PMID: 29895432 DOI: 10.1016/j.jaut.2018.06.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
67 Yu M, Li W, Wang Q, Wang Y, Lu F. Circadian regulator NR1D2 regulates glioblastoma cell proliferation and motility. Oncogene 2018;37:4838-53. [PMID: 29773903 DOI: 10.1038/s41388-018-0319-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
68 Landolt L, Eikrem Ø, Strauss P, Scherer A, Lovett DH, Beisland C, Finne K, Osman T, Ibrahim MM, Gausdal G, Ahmed L, Lorens JB, Thiery JP, Tan TZ, Sekulic M, Marti HP. Clear Cell Renal Cell Carcinoma is linked to Epithelial-to-Mesenchymal Transition and to Fibrosis. Physiol Rep 2017;5:e13305. [PMID: 28596300 DOI: 10.14814/phy2.13305] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
69 Li X, Xu A, Li H, Zhang B, Cao B, Huang J. Novel role of apatinib as a multi-target RTK inhibitor in the direct suppression of hepatocellular carcinoma cells. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1693-1701. [PMID: 29486282 DOI: 10.1016/j.bbadis.2018.02.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
70 Park JS, Lee C, Kim HK, Kim D, Son JB, Ko E, Cho JH, Kim ND, Nan HY, Kim CY, Yoon S, Lee SH, Choi HG. Suppression of the metastatic spread of breast cancer by DN10764 (AZD7762)-mediated inhibition of AXL signaling. Oncotarget 2016;7:83308-18. [PMID: 27829217 DOI: 10.18632/oncotarget.13088] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
71 Wu G, Ma Z, Cheng Y, Hu W, Deng C, Jiang S, Li T, Chen F, Yang Y. Targeting Gas6/TAM in cancer cells and tumor microenvironment. Mol Cancer 2018;17:20. [PMID: 29386018 DOI: 10.1186/s12943-018-0769-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 60] [Article Influence: 11.0] [Reference Citation Analysis]
72 Iida K, Sakai R, Yokoyama S, Kobayashi N, Togo S, Yoshikawa HY, Rawangkan A, Namiki K, Suganuma M. Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL. Sci Rep 2017;7:17770. [PMID: 29259259 DOI: 10.1038/s41598-017-18120-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
73 Wurm S, Steege A, Rom-Jurek EM, van Roeyen CR, Kurtz A, Banas B, Banas MC. CCR7 Is Important for Mesangial Cell Physiology and Repair. J Histochem Cytochem 2018;66:7-22. [PMID: 29077526 DOI: 10.1369/0022155417737975] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
74 Guo Z, Li Y, Zhang D, Ma J. Axl inhibition induces the antitumor immune response which can be further potentiated by PD-1 blockade in the mouse cancer models. Oncotarget 2017;8:89761-74. [PMID: 29163786 DOI: 10.18632/oncotarget.21125] [Cited by in Crossref: 34] [Cited by in F6Publishing: 43] [Article Influence: 6.8] [Reference Citation Analysis]
75 Abboud-Jarrous G, Priya S, Maimon A, Fischman S, Cohen-Elisha M, Czerninski R, Burstyn-Cohen T. Protein S drives oral squamous cell carcinoma tumorigenicity through regulation of AXL. Oncotarget 2017;8:13986-4002. [PMID: 28118606 DOI: 10.18632/oncotarget.14753] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
76 Ruvolo PP, Ma H, Ruvolo VR, Zhang X, Mu H, Schober W, Hernandez I, Gallardo M, Khoury JD, Cortes J, Andreeff M, Post SM. Anexelekto/MER tyrosine kinase inhibitor ONO-7475 arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse mechanisms. Haematologica 2017;102:2048-57. [PMID: 28912176 DOI: 10.3324/haematol.2017.168856] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
77 Liaw BC, Mehrazin R, Baker C, Sfakianos JP, Tsao C. Management of Atypical Renal Cell Carcinomas. Curr Treat Options in Oncol 2017;18. [DOI: 10.1007/s11864-017-0501-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
78 Tannir NM, Schwab G, Grünwald V. Cabozantinib: an Active Novel Multikinase Inhibitor in Renal Cell Carcinoma. Curr Oncol Rep 2017;19:14. [PMID: 28247252 DOI: 10.1007/s11912-017-0566-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
79 Mladinich MC, Schwedes J, Mackow ER. Zika Virus Persistently Infects and Is Basolaterally Released from Primary Human Brain Microvascular Endothelial Cells. mBio 2017;8:e00952-17. [PMID: 28698279 DOI: 10.1128/mBio.00952-17] [Cited by in Crossref: 62] [Cited by in F6Publishing: 70] [Article Influence: 12.4] [Reference Citation Analysis]
80 Sen T, Tong P, Diao L, Li L, Fan Y, Hoff J, Heymach JV, Wang J, Byers LA. Targeting AXL and mTOR Pathway Overcomes Primary and Acquired Resistance to WEE1 Inhibition in Small-Cell Lung Cancer. Clin Cancer Res 2017;23:6239-53. [PMID: 28698200 DOI: 10.1158/1078-0432.CCR-17-1284] [Cited by in Crossref: 45] [Cited by in F6Publishing: 61] [Article Influence: 9.0] [Reference Citation Analysis]
81 Mohr T, Haudek-Prinz V, Slany A, Grillari J, Micksche M, Gerner C. Proteome profiling in IL-1β and VEGF-activated human umbilical vein endothelial cells delineates the interlink between inflammation and angiogenesis. PLoS One 2017;12:e0179065. [PMID: 28617818 DOI: 10.1371/journal.pone.0179065] [Cited by in Crossref: 34] [Cited by in F6Publishing: 53] [Article Influence: 6.8] [Reference Citation Analysis]
82 Onken J, Vajkoczy P, Torka R, Hempt C, Patsouris V, Heppner FL, Radke J. Phospho-AXL is widely expressed in glioblastoma and associated with significant shorter overall survival. Oncotarget 2017;8:50403-14. [PMID: 28881571 DOI: 10.18632/oncotarget.18468] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
83 Zhou S, Liu P, Jiang W, Zhang H. Identification of potential target genes associated with the effect of propranolol on angiosarcoma via microarray analysis. Oncol Lett 2017;13:4267-75. [PMID: 28588707 DOI: 10.3892/ol.2017.5968] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
84 Logan PC, Yango P, Tran ND. Endometrial Stromal and Epithelial Cells Exhibit Unique Aberrant Molecular Defects in Patients With Endometriosis. Reprod Sci 2018;25:140-59. [PMID: 28490276 DOI: 10.1177/1933719117704905] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
85 Corno C, Gatti L, Arrighetti N, Carenini N, Zaffaroni N, Lanzi C, Perego P. Axl molecular targeting counteracts aggressiveness but not platinum-resistance of ovarian carcinoma cells. Biochem Pharmacol 2017;136:40-50. [PMID: 28404378 DOI: 10.1016/j.bcp.2017.04.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
86 Hira VVV, Van Noorden CJF, Carraway HE, Maciejewski JP, Molenaar RJ. Novel therapeutic strategies to target leukemic cells that hijack compartmentalized continuous hematopoietic stem cell niches. Biochim Biophys Acta Rev Cancer. 2017;1868:183-198. [PMID: 28363872 DOI: 10.1016/j.bbcan.2017.03.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
87 Lu Y, Wan J, Yang Z, Lei X, Niu Q, Jiang L, Passtoors WM, Zang A, Fraering PC, Wu F. Regulated intramembrane proteolysis of the AXL receptor kinase generates an intracellular domain that localizes in the nucleus of cancer cells. FASEB J 2017;31:1382-97. [PMID: 28034848 DOI: 10.1096/fj.201600702R] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
88 Davra V, Kimani SG, Calianese D, Birge RB. Ligand Activation of TAM Family Receptors-Implications for Tumor Biology and Therapeutic Response. Cancers (Basel) 2016;8:E107. [PMID: 27916840 DOI: 10.3390/cancers8120107] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 6.2] [Reference Citation Analysis]
89 Zhen Y, Priest SO, Shao WH. Opposing Roles of Tyrosine Kinase Receptors Mer and Axl Determine Clinical Outcomes in Experimental Immune-Mediated Nephritis. J Immunol 2016;197:2187-94. [PMID: 27527599 DOI: 10.4049/jimmunol.1600793] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
90 Rea K, Pinciroli P, Sensi M, Alciato F, Bisaro B, Lozneanu L, Raspagliesi F, Centritto F, Cabodi S, Defilippi P, Avanzi GC, Canevari S, Tomassetti A. Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome. Oncotarget 2015;6:30859-75. [PMID: 26356564 DOI: 10.18632/oncotarget.5087] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
91 Martinelli E, Martini G, Cardone C, Troiani T, Liguori G, Vitagliano D, Napolitano S, Morgillo F, Rinaldi B, Melillo RM. AXL is an oncotarget in human colorectal cancer. Oncotarget. 2015;6:23281-23296. [PMID: 25966280 DOI: 10.18632/oncotarget.3962] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 6.2] [Reference Citation Analysis]
92 Tan L, Zhang Z, Gao D, Luo J, Tu Z, Li Z, Peng L, Ren X, Ding K. 4-Oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as New Axl Kinase Inhibitors. J Med Chem 2016;59:6807-25. [DOI: 10.1021/acs.jmedchem.6b00608] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
93 Shen Y, Cui X, Rong Y, Zhang Z, Xiao L, Zhou T, Chen W. Exogenous Gas6 attenuates silica-induced inflammation on differentiated THP-1 macrophages. Environ Toxicol Pharmacol 2016;45:222-6. [PMID: 27327525 DOI: 10.1016/j.etap.2016.05.029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
94 Reichl P, Mikulits W. Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review). Oncol Rep. 2016;36:613-625. [PMID: 27278244 DOI: 10.3892/or.2016.4842] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
95 Xie S, Li Y, Li X, Wang L, Yang N, Wang Y, Wei H. Mer receptor tyrosine kinase is frequently overexpressed in human non-small cell lung cancer, confirming resistance to erlotinib. Oncotarget 2015;6:9206-19. [PMID: 25826078 DOI: 10.18632/oncotarget.3280] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
96 Mukherjee SK, Wilhelm A, Antoniades CG. TAM receptor tyrosine kinase function and the immunopathology of liver disease. Am J Physiol Gastrointest Liver Physiol 2016;310:G899-905. [PMID: 26867565 DOI: 10.1152/ajpgi.00382.2015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
97 Senft D, Ronai ZA. Immunogenic, cellular, and angiogenic drivers of tumor dormancy--a melanoma view. Pigment Cell Melanoma Res 2016;29:27-42. [PMID: 26514653 DOI: 10.1111/pcmr.12432] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
98 Fritz HK, Gustafsson A, Ljungberg B, Ceder Y, Axelson H, Dahlbäck B. The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels. PLoS One 2015;10:e0135991. [PMID: 26287733 DOI: 10.1371/journal.pone.0135991] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
99 Lan X, Lu G, Yuan C, Mao S, Jiang W, Chen Y, Jin X, Xia Q. Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4. J Cancer Res Clin Oncol 2016;142:177-85. [PMID: 26206483 DOI: 10.1007/s00432-015-2020-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
100 Trino S, De Luca L, Simeon V, Laurenzana I, Morano A, Caivano A, La Rocca F, Pietrantuono G, Bianchino G, Grieco V, Signorino E, Fragasso A, Bochicchio MT, Venturi C, Rosti G, Martinelli G, Del Vecchio L, Cilloni D, Musto P. Inverse regulation of bridging integrator 1 and BCR-ABL1 in chronic myeloid leukemia. Tumour Biol 2016;37:217-25. [PMID: 26194865 DOI: 10.1007/s13277-015-3772-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
101 Okimoto RA, Bivona TG. AXL receptor tyrosine kinase as a therapeutic target in NSCLC. Lung Cancer (Auckl) 2015;6:27-34. [PMID: 28210148 DOI: 10.2147/LCTT.S60438] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
102 Wu KS, Hung YJ, Lee CH, Hsiao FC, Hsieh PS. The Involvement of GAS6 Signaling in the Development of Obesity and Associated Inflammation. Int J Endocrinol 2015;2015:202513. [PMID: 25954309 DOI: 10.1155/2015/202513] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
103 Beier JI, Jokinen JD, Holz GE, Whang PS, Martin AM, Warner NL, Arteel GE, Lukashevich IS. Novel mechanism of arenavirus-induced liver pathology. PLoS One 2015;10:e0122839. [PMID: 25822203 DOI: 10.1371/journal.pone.0122839] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]